Edition:
India

People: Celon Pharma SA (CLNP.WA)

CLNP.WA on Warsaw Stock Exchange

41.25PLN
20 Sep 2019
Change (% chg)

-0.05zł (-0.12%)
Prev Close
41.30zł
Open
41.80zł
Day's High
41.90zł
Day's Low
41.25zł
Volume
5,956
Avg. Vol
8,083
52-wk High
51.10zł
52-wk Low
28.25zł

Wieczorek, Maciej 

Dr. Maciej Wieczorek serves as Chairman of the Management Board and Chief Executive Officer of Celon Pharma S.A. He is Vice Chairman of the Management Board of Action for Development of Research Sp. z o.o. He has served as Chairman of the Management Board of Novazil Therapeutics, Celon Services and held the same position at Mabion S.A. until 2016. He holds a Doctorate of Medicine degree in Medical Biology from Uniwersytet Medyczny w Lodzi (2009), as well as a degree in Industrial Management from Politechnika Warszawska. Dr. Wieczorek has completed MBA studies program at Szkola Glowna Handlowa in Warsaw in cooperation with University of Minnesota.

Basic Compensation

Total Annual Compensation, PLN --
Restricted Stock Award, PLN --
Long-Term Incentive Plans, PLN --
All Other, PLN 7,650,000
Fiscal Year Total, PLN 7,650,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --